Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access programGiuseppe Procopio, Elena Verzoni, Giacomo Cartenì et al.|Journal for ImmunoTherapy of Cancer|2019Cited by 140
Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS MetastasesDiego Cortinovis, Angelo Delmonte, Rita Chiari et al.|Anticancer Research|2019Cited by 38
A case of furuncular myiasis associated with systemic inflammationStefania Varani, Domenico Otranto, Davide Tassinari et al.|Parasitology International|2007Cited by 21
Efficacy and safety data from patients with advanced squamous NSCLC and brain metastases participating in the nivolumab Expanded Access Programme (EAP) in ItalyPaolo Bidoli, Angelo Delmonte, Rita Chiari et al.|Annals of Oncology|2016Cited by 19
Fighting Cancer in Coronavirus Disease Era: Organization of Work in Medical Oncology Departments in Emilia Romagna Region of ItalyAlba A. Brandes, Carmine Pinto, Andrea Ardizzoni et al.|Future Oncology|2020Cited by 16